[1]
Yanai, H. et al. 2025. The Long-Term Effects of the Selective Inhibitor of Urate Transporter 1, Dotinurad, on Metabolic Parameters and Renal Function in Japanese Patients With Asymptomatic Hyperuricemia. Journal of Clinical Medicine Research. 17, 6 (Jul. 2025), 320–333. DOI:https://doi.org/10.14740/jocmr6250.